TY - CHAP M1 - Book, Section TI - Stroke Syndromes A1 - Go, Steven A1 - Kornegay, Josh A2 - Tintinalli, Judith E. A2 - Ma, O. John A2 - Yealy, Donald M. A2 - Meckler, Garth D. A2 - Stapczynski, J. Stephan A2 - Cline, David M. A2 - Thomas, Stephen H. PY - 2020 T2 - Tintinalli's Emergency Medicine: A Comprehensive Study Guide, 9e AB - Content Update: Tenecteplase (TNKase) Thrombolytic Treatment, December 2023Information is provided in the section entitled Tenecteplase (TNKase) under Thrombolysis Background. Please also review current TNKase dosing recommendations.Terminology: rtPA (recombinant tissue plasminogen activator) is a drug class that includes alteplase and tenecteplase. Early clinical work on thrombolytics used rtPA interchangeably with alteplase because it was the only agent available. Terminology has been harmonized wherever possible to distinguish tenecteplase and alteplase. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accessmedicine.mhmedical.com/content.aspx?aid=1205624822 ER -